Cargando…

Identification of hub genes involved in cisplatin resistance in head and neck cancer

BACKGROUND: Cisplatin resistance is one of the major contributors to the poor survival rate among head and neck cancer (HNC) patients. Focusing on the protein–protein interaction rather than a single protein could provide a better understanding of drug resistance. Thus, this study aimed to identify...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chaudhary, Raushan Kumar, Khanal, Pukar, Mateti, Uday Venkat, Shastry, C. S., Shetty, Jayarama
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9886788/ https://www.ncbi.nlm.nih.gov/pubmed/36715825 http://dx.doi.org/10.1186/s43141-023-00468-y

Ejemplares similares

Healthcare Scheme to Overcome Financial Burden Associated with Chemoradiation Therapy in Head and Neck Cancer Patients: A Retrospective Single Centre Study
por: Johnson, Allen P, et al.
Publicado: (2023)

Development of evidence-based indicators for the detection of drug-related problems among ovarian cancer patients
por: Rawal, Kala Bahadur, et al.
Publicado: (2023)

System Biology Approach to Identify the Hub Genes and Pathways Associated with Human H5N1 Infection
por: Chaudhary, Raushan Kumar, et al.
Publicado: (2023)

Development and validation of patient information leaflet for coronary heart disease patients
por: Vinay, B. C., et al.
Publicado: (2021)

Updates on biomedical waste management during COVID-19: The Indian scenario
por: Chand, Sharad, et al.
Publicado: (2021)

Perception of Availability, Accessibility, and Affordability of COVID-19 Vaccines and Hesitancy: A Cross-Sectional Study in India
por: Ayappan, Akshay, et al.
Publicado: (2022)

Emerging doctor of pharmacy program in India: A survey on general opinion of selected educated Indians
por: Garipelly, Raman, et al.
Publicado: (2012)

Decitabine Rescues Cisplatin Resistance in Head and Neck Squamous Cell Carcinoma
por: Viet, Chi T., et al.
Publicado: (2014)

MicroRNAs as the pivotal regulators of cisplatin resistance in head and neck cancers
por: Tolue Ghasaban, Faezeh, et al.
Publicado: (2023)

Health-care cost of diabetes in South India: A cost of illness study
por: Akari, Sadanandam, et al.
Publicado: (2013)

Why angiotensin converting enzyme inhibitors and angiotensin II receptor blockers are not prescribed in the management of hypertension among hemodialysis patients in India
por: Mateti, Uday Venkat, et al.
Publicado: (2014)

Implementing awareness program on evidence based medicine for pharmacy students
por: Ganneboina, Jyothirmai, et al.
Publicado: (2013)

Identification of Hub Genes Associated With Development of Head and Neck Squamous Cell Carcinoma by Integrated Bioinformatics Analysis
por: Li, Chia Ying, et al.
Publicado: (2020)

Identification of cisplatin-resistant factor by integration of transcriptomic and proteomic data using head and neck carcinoma cell lines
por: Inukai, Daisuke, et al.
Publicado: (2020)

Insulin chewing gum: Need of the day for diabetic patients
por: Mateti, Uday Venkat, et al.
Publicado: (2011)

FGFR signaling regulates resistance of head and neck cancer stem cells to cisplatin
por: McDermott, Sarah C., et al.
Publicado: (2018)

Mechanisms of Cisplatin Resistance in HPV Negative Head and Neck Squamous Cell Carcinomas
por: Griso, Ana Belén, et al.
Publicado: (2022)

A Combined Systemic Strategy for Overcoming Cisplatin Resistance in Head and Neck Cancer: From Target Identification to Drug Discovery
por: Chen, Yin-Ju, et al.
Publicado: (2020)

Assessment of treatment interruption among pulmonary tuberculosis patients: A cross-sectional study
por: Gorityala, Satya Bhgath, et al.
Publicado: (2015)

Examination of care processes and treatment optimization for head and neck cancer patients in a community setting “hub and hub” model
por: Sethi, Harleen K., et al.
Publicado: (2022)

Chemoradiotherapy With Generic Cisplatin Formulations for Head and Neck Cancers
por: Shimada, Rie, et al.
Publicado: (2018)

Inhibition of Glutaredoxin 5 predisposes Cisplatin-resistant Head and Neck Cancer Cells to Ferroptosis
por: Lee, Jaewang, et al.
Publicado: (2020)

MicroRNA-21 induces cisplatin resistance in head and neck squamous cell carcinoma
por: Sheng, Shuyan, et al.
Publicado: (2022)

The Vitamin D Receptor–BIM Axis Overcomes Cisplatin Resistance in Head and Neck Cancer
por: Khamis, Aya, et al.
Publicado: (2022)

Transcriptomic and Proteomic Profiles for Elucidating Cisplatin Resistance in Head-and-Neck Squamous Cell Carcinoma
por: Garcia-Mayea, Yoelsis, et al.
Publicado: (2022)

Identification of hub lncRNAs in head and neck cancer based on weighted gene co‐expression network analysis and experiments
por: Lina, Shao
Publicado: (2021)

Comparison of vinorelbine with cisplatin in concomitant chemoradiotherapy in head and neck carcinoma
por: Devleena,, et al.
Publicado: (2010)

Head and neck irradiation modulates pharmacokinetics of 5-fluorouracil and cisplatin
por: Hsieh, Chen-Hsi, et al.
Publicado: (2013)

Prognostic Factors for the Therapeutic Performance of Cisplatin in Head and Neck Malignancies
por: Jungbauer, Frederic, et al.
Publicado: (2022)

Drug utilization pattern in South Indian pediatric population: A prospective study
por: Thiruthopu, Nimbagiri Swamy, et al.
Publicado: (2014)

Risk factor assessment of stroke and its awareness among stroke survivors: A prospective study
por: Shravani, K., et al.
Publicado: (2015)

Identification of novel hub genes associated with lymph node metastasis of head and neck squamous cell carcinoma by completive bioinformatics analysis
por: Lu, Honglue, et al.
Publicado: (2021)

Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis
por: Roh, Jong-Lyel, et al.
Publicado: (2016)

Pattern of Angiotensin-Converting Enzyme Inhibitors Induced Adverse Drug Reactions in South Indian Teaching Hospital
por: Mateti, Uday Venkat, et al.
Publicado: (2012)

A survey on medicines safety and usage in community pharmacy
por: Prabhu, Varsha A., et al.
Publicado: (2013)

Assessment of drug-drug interactions in hypertensive patients at a superspeciality hospital
por: Sivva, Divya, et al.
Publicado: (2015)

Mitochondrial Involvement in Cisplatin Resistance
por: Cocetta, Veronica, et al.
Publicado: (2019)

Over-expression of BAG-1 in head and neck squamous cell carcinomas (HNSCC) is associated with cisplatin-resistance
por: Liu, Shutong, et al.
Publicado: (2017)

Regulation of cisplatin-resistant head and neck squamous cell carcinoma by the SRC/ETS-1 signaling pathway
por: Yang, Zejia, et al.
Publicado: (2019)

Valproic Acid Synergizes With Cisplatin and Cetuximab in vitro and in vivo in Head and Neck Cancer by Targeting the Mechanisms of Resistance
por: Iannelli, Federica, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fo5ctc1j986vge2o8ucusjitsh